Aligned Genetics Inc (238120) — Cash Flow Quality Index
Aligned Genetics Inc (238120) has a Cash Flow Quality Index of -2.19x as of September 2025. Operating cash flow of ₩-2.04 Billion is below net income of ₩933.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Aligned Genetics Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aligned Genetics Inc Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Aligned Genetics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Aligned Genetics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aligned Genetics Inc (2019–2024)
Year-by-year earnings quality comparison for Aligned Genetics Inc. For live market cap and the full company financial profile, see 238120 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | ₩3.07 Billion | ₩4.13 Billion | ▼ -15.6% |
| 2023 | 0.88x | ₩2.85 Billion | ₩3.24 Billion | ▼ -7.6% |
| 2022 | 0.95x | ₩2.22 Billion | ₩2.33 Billion | ▲ +3782.9% |
| 2021 | 0.02x | ₩135.97 Million | ₩5.54 Billion | ▼ -67.8% |
| 2020 | 0.08x | ₩35.67 Million | ₩468.23 Million | ▼ -98.7% |
| 2019 | 5.65x | ₩659.29 Million | ₩116.74 Million | — |